These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9044298)

  • 1. Advanced glycation end-products in the peritoneal fluid and in the peritoneal membrane of continuous ambulant peritoneal dialysis patients.
    Mahiout A; Ehlerding G; Brunkhorst R
    Nephrol Dial Transplant; 1996; 11 Suppl 5():2-6. PubMed ID: 9044298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical detection of an AGE, a ligand for macrophage receptor, in peritoneum of CAPD patients.
    Nakamura S; Tobita K; Tachikawa T; Akamatsu S; Ohno Y; Kan A; Katsuragawa M; Yasumura K; Miyazaki S; Sakai S; Morita T; Hirashawa Y; Niwa T
    Kidney Int Suppl; 2003 May; (84):S152-7. PubMed ID: 12694334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds.
    Miyata T; Horie K; Ueda Y; Fujita Y; Izuhara Y; Hirano H; Uchida K; Saito A; van Ypersele de Strihou C; Kurokawa K
    Kidney Int; 2000 Jul; 58(1):425-35. PubMed ID: 10886591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycated albumin in serum and dialysate of patients on continuous ambulatory peritoneal dialysis.
    Lamb E; Cattell WR; Dawnay A
    Clin Sci (Lond); 1993 Jun; 84(6):619-26. PubMed ID: 8334808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD.
    Nakayama M; Kawaguchi Y; Yamada K; Hasegawa T; Takazoe K; Katoh N; Hayakawa H; Osaka N; Yamamoto H; Ogawa A; Kubo H; Shigematsu T; Sakai O; Horiuchi S
    Kidney Int; 1997 Jan; 51(1):182-6. PubMed ID: 8995732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration.
    Honda K; Nitta K; Horita S; Yumura W; Nihei H; Nagai R; Ikeda K; Horiuchi S
    Nephrol Dial Transplant; 1999 Jun; 14(6):1541-9. PubMed ID: 10383022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal accumulation of AGE and peritoneal membrane permeability.
    Park MS; Lee HA; Chu WS; Yang DH; Hwang SD
    Perit Dial Int; 2000; 20(4):452-60. PubMed ID: 11007378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amadori albumin and advanced glycation end-product formation in peritoneal dialysis using icodextrin.
    Posthuma N; ter Wee PM; Niessen H; Donker AJ; Verbrugh HA; Schalkwijk CG
    Perit Dial Int; 2001; 21(1):43-51. PubMed ID: 11280495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exfoliated mesothelial cell and CA-125 in automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) patients.
    Kanjanabuch T; Puttipittayathorn N; Leelahavanichkul A; Lieusuwan S; Katavetin P; Mahatanan N; Sriudom K; Chirananthavat T; Thongbor N; Eiam-Ong S
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S119-25. PubMed ID: 22043578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro formation of advanced glycation end products in peritoneal dialysis fluid.
    Lamb EJ; Cattell WR; Dawnay AB
    Kidney Int; 1995 Jun; 47(6):1768-74. PubMed ID: 7643548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term changes in transperitoneal water transport during continuous ambulatory peritoneal dialysis.
    Wideröe TE; Smeby LC; Mjåland S; Dahl K; Berg KJ; Wessel Aas T
    Nephron; 1984; 38(4):238-47. PubMed ID: 6514073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end products are associated with immature angiogenesis and peritoneal dysfunction in patients on peritoneal dialysis.
    Nakano T; Mizumasa T; Kuroki Y; Eriguchi M; Yoshida H; Taniguchi M; Masutani K; Tsuruya K; Kitazono T
    Perit Dial Int; 2020 Jan; 40(1):67-75. PubMed ID: 32063152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraperitoneal infusion of glucose-based dialysate in the rat--an animal model for the study of peritoneal advanced glycation end-products formation and effect on peritoneal transport.
    Zeltzer E; Klein O; Rashid G; Katz D; Korzets Z; Bernheim J
    Perit Dial Int; 2000; 20(6):656-61. PubMed ID: 11216555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients.
    Wang T; Heimbürger O; Waniewski J; Bergström J; Lindholm B
    Nephrol Dial Transplant; 1998 May; 13(5):1242-9. PubMed ID: 9623561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
    Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
    J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in fluid and solute transport between diabetic and nondiabetic patients at the onset of CAPD.
    Serlie MJ; Struijk DG; de Blok K; Krediet RT
    Adv Perit Dial; 1997; 13():29-32. PubMed ID: 9360646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose dialysate induces mitochondrial DNA damage in peritoneal mesothelial cells.
    Ishibashi Y; Sugimoto T; Ichikawa Y; Akatsuka A; Miyata T; Nangaku M; Tagawa H; Kurokawa K
    Perit Dial Int; 2002; 22(1):11-21. PubMed ID: 11929138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal protein loss in patients with high peritoneal permeability: comparison between continuous ambulatory peritoneal dialysis and daytime intermittent peritoneal dialysis.
    Cueto-Manzano AM; Gamba G; Correa-Rotter R
    Arch Med Res; 2001; 32(3):197-201. PubMed ID: 11395184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth factors in continuous ambulatory peritoneal dialysis effluent. Their relation with peritoneal transport of small solutes.
    Lai KN; Lai KB; Szeto CC; Lam CW; Leung JC
    Am J Nephrol; 1999; 19(3):416-22. PubMed ID: 10393381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation end-products and peritoneal sclerosis.
    Nakamura S; Niwa T
    Semin Nephrol; 2004 Sep; 24(5):502-5. PubMed ID: 15490420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.